AUR-101 by Aurigene Oncology for Psoriatic Arthritis: Likelihood of Approval

AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Psoriatic Arthritis.

Light physical activity emerges as powerful tool to reverse childhood inactivity’s cholesterol risk

Increased sedentary time in childhood can raise cholesterol levels by two thirds as an adult, leading to heart problems and even premature death – but

December 15, 2023

Idaho Medical Group May Close if It’s Not Sold

As the healthcare landscape continues to shift nationwide, Idaho’s Saltzer Health, which was recently acquired by Salt Lake City-based Intermountain Healthcare, is set to shutter

January 26, 2024

Medical schools need to offer students alternatives to state physician health programs

In recent years, there has been a growing awareness about the mental health challenges faced by medical students. The pandemic only exacerbated concerns about med

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.